References
Kerr JFK, Wyllie AH, Currie AH: Apoptosis, a basic biological phenomenon with a wider implication in tissue kinetics. Br J Cancer 26: 239–245, 1972
Nagata S, Golstein P: The Fas death factor. Science 267: 144–150, 1995
Raff MC: Social controls on cell survival and cell death. Nature 356: 397–400, 1992
Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Met Rev 11: 95–103, 1992
Potten CS: The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer and Metastasis Rev 11: 179–195, 1992
White E, Cipriani R, Sabattini P, Denton A: Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol 65: 2968–2978, 1991
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128, 1992
Dedera DA, Waller KE, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML: Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis and malignant lymphomas in transgenic mice. Cell 74: 833–843, 1993
Harrington EA, Fanidi A, Evan GI: Oncogenes and cell death. Curr Opin Gen Dev 4: 120–129, 1994
Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 is an inner mithochondrial membrane protein that blocks cell death. Nature 348: 334–336, 1990
Bissonnette RP, Echeverri F, Mahboudi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552–553, 1992
Libermann DA, Hoffman B, Steinman RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199–210, 1995
Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58–61, 1989
Folkman J: Cancer. In: Tumor angiogenesis. F. Becker, 355–388, Plenum Publishing Corporation: New York, 1975
Algire GH, Chalkley HW: Vascular reactions of normal and malignant tissues in vivo. 1. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 6: 73–85, 1945
Knighton D, Ausprunk D, Tapper D, Folkman J: Studies of the avascular and vascular phases of tumor growth in the chick embryo. Br J Cancer 35: 347–356, 1977
Gimbrone MAJ, Cotran RS, Folkman J: Tumor growth and neovascularization: An experimental model using rabbit cornea. J Natl Cancer Inst 52: 413–427, 1974
Brem S, Brem H, Folkman J, Finkelstein D, Patz A: Prolonged tumor dormancy by prevention of vascularization in the vitreous. Cancer Research 36: 2807–2812, 1976
Folkman J: Tumor angiogenesis: therapeutic implications. New Engl J Med 285: 1182–1186, 1971
Folkman J: Drug and Market Development 6: 221, 1995
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases of a Lewis lung carcinoma. Cell 79: 315–328, 1994
Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1: 149–153, 1995
Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556, 1980
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501, 1992
Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R: Determination of the length of the histological stages of apoptosis in normal liver and altered hepatic foci of rats. Carcinogenesis 11: 847–853, 1990
Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31–46, 1992
parangi S, O'Reilly MS, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D: Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Acad Sci USA 90: 2002–2007, 1996
Harrington EA, Bennett MR, Fanidi A, Evan GI: EMBO J 13: 3286–3295, 1994
Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R: The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res 55: 2563–2569, 1995
Nicosia RF, Tchao R, Leighton J: Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res 43: 2159–2166, 1983
Hamada J, Cavanaugh PG, Lotan O, Nicolson GL: Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer 66: 349–354, 1992
Eskey JC, Koretsky AP, Domach MM, Jain RK: Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: Direct measurement by p31 NMR. Proc Natl Acad Sci 90: 2646–2650, 1993
Flier JS, Mueckler MM, Usher P, Lodish HF: Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492–1495, 1987
Valera A, Pujol A, Gregori X, Riu E, Visa J, Bosch F: Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB 9: 1067–1078, 1995
Kan O, Baldwin SA, Whetton AD: Apoptosis is regulated by the rate of glucose transport in an IL-3-dependent haemopoietic cell line. Biochemical Society Transactions 22: 1994
Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 370: 88–91, 1996
Fidler IJ: Cancer metastasis. Br Med Bulletin 47: 157–177, 1991
Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86: 45–48, 1994
Crowley NJ, Seigler HF: Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg 127: 1303–1308, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holmgren, L. Antiangiogenis restricted tumor dormancy. Cancer Metast Rev 15, 241–245 (1996). https://doi.org/10.1007/BF00437478
Issue Date:
DOI: https://doi.org/10.1007/BF00437478